Rates by insurance carrier
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|
Indiana rates for HCPCS C9076
Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Rates data updated July 2026.
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|